TBPH · Theravance Biopharma, Inc.
$16.86
+0.00 (+0.00%)
At close · Jul 24
Market Cap
$869.18M
Shares
51.55M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Áine Miller | Senior Vice President, Development and Head of Ireland Office | Terminated | 2026-06-23 |
Key facts
CIK
1583107
CUSIP
G8807B106
13F (30d)
21 filings
21 filers
Visit website
Investor relations